Effects of homeopathy in mice experimentally infected with Trypanosoma cruzi

Homeopathy

Volumn 97, Issue 2, 2008, Pages 65-69

  Rodrigues de Almeida, Luciana ^a   Caroline de Oliveira Campos, Mônica ^b   Miraglia Herrera, Heitor ^b   Villano Bonamin, Leoni ^c   Henrique da Fonseca, Adivaldo ^a  

^a FEDERAL RURAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Pathology Laboratory   (Brazil)

Author keywords

Biotherapy; Chagas disease; Homeopathy; Mice; Nosode; Phosphorus; Trypanosoma cruzi

Indexed keywords

PHOSPHORUS 32;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL THERAPY; CHAGAS DISEASE; CONTROLLED STUDY; HOMEOPATHY; INOCULATION; LYMPHOCYTE; MALE; MORTALITY; MOUSE; NONHUMAN; PARASITEMIA; PATHOGENICITY; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ANIMALS; CHAGAS DISEASE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HOMEOPATHY; MICE; MICE, INBRED C57BL; PARASITEMIA; PHOSPHORUS; PHYTOTHERAPY; PLANT EXTRACTS; RANDOM ALLOCATION; TRYPANOSOMA CRUZI;

EID: 42649133848     PISSN: 14754916     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.homp.2008.02.009     Document Type: Article

References (22)

1. Brener Z., and Gazzinelli R.T. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas disease. Int Arch Allergy Immunol 114 (1997) 103-110
2. Tarleton R.L. Parasite persistence in the aetiology of Chagas disease. Int J Parasitol 31 (2001) 550-554
3. Bastide M., Lagache A., and Lemaire-Misonne C. Le paradigme des signifiants: schème d'information applicable à l'Immunologie et à l'Homéopathie. Rev Int Sistémique 9 (1995) 237-249
4. Wynn S.G. Studies on use of homeopathy in animals. J Am Vet Med Assoc 212 (1998) 719-724
5. Jonas W.B., and Dilnner D.K. Protection of mice from tularemia infection with ultra-low, serial agitated dilution prepared from Franciscella tularensis infected tissue. J Scient Explor 14 (2000) 35-52
6. Neill H. Homeopathic nosodes. Vet Rec 133 (1993) 48
7. Marino A.P., Silva A.A., Santos P.V., et al. CC-chemokine receptors: a potential therapeutic target for Trypanosoma cruzi-elicited myocarditis. Mem Inst Oswaldo Cruz 1 (2005) 93-96
8. Hahnemann S. Doenças Crônicas. 2nd edn (1835), GEHSP Benoit Mure, São Paulo 202 pp.
9. Andrade MAM, Nascimento MM, Carillo Jr., R. Estudo da Origem Diatésica da Doença de Chagas. In: IV Congresso da Associação Brasileira de Reciclagem e Assistência em Homeopatia, 2005. Anais. São Paulo, 2005.
10. Costa R. Homeopatia Atualizada (1988), Editora Vozes, Petrópolis
11. Camargo M.E. Improved technique of indirect immunofluorescence for serological diagnosis for toxoplasmosis. Rev Inst Med Trop São Paulo 3 (1964) 117-118
12. Clarke J.H. Clinical repertory of materia medica (1904), Homeopathic Publishing Company, London
13. Boerick W. Manual de Matéria Médica Homeopática. 1st edn (1997), Robe Editorial, São Paulo 429 p
14. Carillo Jr. R. Homeopatia, Medicina Interna e Terapêutica. 1st edn (2000), Ed. Santos, São Paulo
15. Brener Z., Andrade Z.A., and Barral-Netto M. Trypanosoma cruzi e Doença de Chagas. 2nd edn (2000), Guanabara Koogan, Rio de Janeiro 431 p
16. Hunter C.A., Ellis-Neyes L.A., Slifer T., et al. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J Immunol 158 (1997) 3311-3316
17. Machado HHS. Eficácia anti-helmíntica de Medicamentos Convencional e Homeopáticos sobre Trichostrongylus colubriformis em coelhos infectados experimentalmente. Msc dissertation, Universidade Federal Rural do Rio de Janeiro, 2003.
18. Heine H., and Schmolz M. Immunoregulation via 'bystander suppression' needs minute amounts of substances-a basis for homeopathic therapy?. Med Hyphotheses 54 (2000) 392-393
19. Abrahamsohn I.A., and Coffman R.L. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J Immunol 155 (1995) 3955-3963
20. Hernandez-Becerril N., Nava A., Reyes P.A., et al. IgG subclass reactivity to Trypanosoma cruzi in chronic chagasic patients. Arch Cardiol Mex 71 (2001) 199-205
21. Zauza P.L., and Borges-Pereira J. Sera levels of anti-Trypanosoma cruzi IgG in the course of chronic chagasic cardiopathy in 10 years. Rev Soc Bras Med Trop 34 (2001) 399-405
22. Morgan J., Dias J.C., Gontijo E.D., et al. Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease. Am J Trop Med Hyg 55 (1996) 355-359